Carcinoid and Neuroendocrine Tumor Program

The Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program provides comprehensive multidisciplinary care for patients with carcinoid and neuroendocrine tumors. Our team has access to the most current techniques for diagnosis and treatment and is one of the few such programs in the United States.

Neuroendocrine Tumors and Carcinoids

Neuroendocrine tumors are cancers of certain endocrine cells. In addition to growing and spreading like other cancers, they can produce hormones. Neuroendocrine tumors in adults commonly originate in the small intestine (carcinoid), pancreas, lung, colon, rectum, appendix and stomach, but many other primary sites are possible.

Although most neuroendocrine tumors grow more slowly than many other cancers, some (e.g., high grade, poorly differentiated or small cell cancer) grow very quickly. Some neuroendocrine tumors are named by the hormones that they produce, such as gastrinoma (gastrin), insulinoma (insulin), glucagonoma (glucagon), VIPoma (VIP) and carcinoid (serotonin).

Adrenal pheochromocytoma, paraganglioma and medullary carcinoma of the thyroid are names of other rare neuroendocrine tumors.

Diagnostics and Treatment

The Carcinoid and Neuroendocrine Tumor Program provides comprehensive treatment for all types of neuroendocrine tumors.

For Referring Physicians

The Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program, led by Edward M. Wolin, MD (medical oncology), works closely with referring physicians to coordinate management, typically remaining in close touch by letter and phone. For new patient referrals, please call or send a message to our team.

Have Questions or Need a Referral?

Call us or send a message to the Carcinoid and Neuroendocrine Tumor Program team. You can also have us call you back at your convenience.

Available 24 hours a day

(1-800-233-2771)

Monday–Friday, 8 a.m.-5 p.m., Pacific Time (U.S.)